Click for best price
Postpemic Era Clinical Trials Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
(Post-pandemic Era)-Global Clinical Trials Market Segment Research Report 2022?, which aims to sort out the development status and trends of the Clinical Trials industry at home and abroad, estimate the overall market scale of the Clinical Trials industry and the market share of major countries, Clinical Trials industry, and study and judge the downstream market demand of Clinical Trials through systematic research, Analyze the competition pattern of Clinical Trials, so as to help solve the pain points of various stakeholders in Clinical Trials industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Clinical Trials Market by Research Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Clinical Trials Market?
Quintiles IMS
Paraxel International Corporation
Charles River Laboratories
ICON plc
SGS SA
Pharmaceutical Product Development, LLC
Wuxi AppTec Inc.
PRA Health Sciences
Chiltern International Ltd.
INC Research
Major Type of Clinical Trials Covered in Research report:
Phase I
Phase II
Phase III
Phase IV
Application Segments Covered in Research Market
Interventional
Observational
Expanded Access
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
(Post-pandemic Era)-Global Clinical Trials Market Segment Research Report 2022 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
80 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Global Clinical Trials Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Clinical Trials Market by Value
2.2.1 Global Clinical Trials Revenue by Type
2.2.2 Global Clinical Trials Market by Value
2.3 Global Clinical Trials Market by Sales
2.3.1 Global Clinical Trials Sales by Type
2.3.2 Global Clinical Trials Market by Sales
3. The Major Driver of Clinical Trials Industry
3.1 Historical & Forecast Global Clinical Trials Sales and Revenue (2018-2028)
3.2 Largest Application for Clinical Trials (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Clinical Trials Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Clinical Trials Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Clinical Trials Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Clinical Trials Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Clinical Trials Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Clinical Trials Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Clinical Trials Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Clinical Trials Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Clinical Trials Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Clinical Trials Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Clinical Trials Average Price Trend
13.1 Market Price for Each Type of Clinical Trials in US (2018-2022)
13.2 Market Price for Each Type of Clinical Trials in Europe (2018-2022)
13.3 Market Price for Each Type of Clinical Trials in China (2018-2022)
13.4 Market Price for Each Type of Clinical Trials in Japan (2018-2022)
13.5 Market Price for Each Type of Clinical Trials in India (2018-2022)
13.6 Market Price for Each Type of Clinical Trials in Korea (2018-2022)
13.7 Market Price for Each Type of Clinical Trials in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Clinical Trials in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Clinical Trials Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Clinical Trials
15. Clinical Trials Competitive Landscape
15.1 Quintiles IMS
15.1.1 Quintiles IMS Company Profiles
15.1.2 Quintiles IMS Product Introduction
15.1.3 Quintiles IMS Clinical Trials Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 Paraxel International Corporation
15.2.1 Paraxel International Corporation Company Profiles
15.2.2 Paraxel International Corporation Product Introduction
15.2.3 Paraxel International Corporation Clinical Trials Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Charles River Laboratories
15.3.1 Charles River Laboratories Company Profiles
15.3.2 Charles River Laboratories Product Introduction
15.3.3 Charles River Laboratories Clinical Trials Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 ICON plc
15.4.1 ICON plc Company Profiles
15.4.2 ICON plc Product Introduction
15.4.3 ICON plc Clinical Trials Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 SGS SA
15.5.1 SGS SA Company Profiles
15.5.2 SGS SA Product Introduction
15.5.3 SGS SA Clinical Trials Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 Pharmaceutical Product Development, LLC
15.6.1 Pharmaceutical Product Development, LLC Company Profiles
15.6.2 Pharmaceutical Product Development, LLC Product Introduction
15.6.3 Pharmaceutical Product Development, LLC Clinical Trials Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 Wuxi AppTec Inc.
15.7.1 Wuxi AppTec Inc. Company Profiles
15.7.2 Wuxi AppTec Inc. Product Introduction
15.7.3 Wuxi AppTec Inc. Clinical Trials Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 PRA Health Sciences
15.8.1 PRA Health Sciences Company Profiles
15.8.2 PRA Health Sciences Product Introduction
15.8.3 PRA Health Sciences Clinical Trials Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 Chiltern International Ltd.
15.9.1 Chiltern International Ltd. Company Profiles
15.9.2 Chiltern International Ltd. Product Introduction
15.9.3 Chiltern International Ltd. Clinical Trials Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 INC Research
15.10.1 INC Research Company Profiles
15.10.2 INC Research Product Introduction
15.10.3 INC Research Clinical Trials Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
16. Conclusion
17. Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure 1. Total Sales by Application of Clinical Trials Industry (Volume)
Figure 2. Clinical Trials Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Clinical Trials Revenue in 2022
Figure 5. US Clinical Trials Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Clinical Trials Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Clinical Trials Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Clinical Trials Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Clinical Trials Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Clinical Trials Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Clinical Trials Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Clinical Trials Revenue, by Type (Million USD) (2018-2028)
Table 4. Clinical Trials Sales, by Type (K Unit) (2018-2028)
Table 5. Clinical Trials Sales (K Unit) by Application (2018-2028)
Table 6. Clinical Trials Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Clinical Trials Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Clinical Trials Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Clinical Trials Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Clinical Trials Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Clinical Trials Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Clinical Trials Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Clinical Trials Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Clinical Trials Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Clinical Trials in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Clinical Trials in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Clinical Trials in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Clinical Trials in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Clinical Trials in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Clinical Trials in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Clinical Trials in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Quintiles IMS Profiles
Table 61. Quintiles IMS Clinical Trials Product Introduction
Table 62. Quintiles IMS Clinical Trials Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Quintiles IMS Strategic initiatives
Table 64. Paraxel International Corporation Profiles
Table 65. Paraxel International Corporation Clinical Trials Product Introduction
Table 66. Paraxel International Corporation Clinical Trials Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. Paraxel International Corporation Strategic initiatives
Table 68. Charles River Laboratories Profiles
Table 69. Charles River Laboratories Clinical Trials Product Introduction
Table 70. Charles River Laboratories Clinical Trials Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Charles River Laboratories Strategic initiatives
Table 72. ICON plc Profiles
Table 73. ICON plc Clinical Trials Product Introduction
Table 74. ICON plc Clinical Trials Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. ICON plc Strategic initiatives
Table 76. SGS SA Profiles
Table 77. SGS SA Clinical Trials Product Introduction
Table 78. SGS SA Clinical Trials Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. SGS SA Strategic initiatives
Table 80. Pharmaceutical Product Development, LLC Profiles
Table 81. Pharmaceutical Product Development, LLC Clinical Trials Product Introduction
Table 82. Pharmaceutical Product Development, LLC Clinical Trials Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Pharmaceutical Product Development, LLC Strategic initiatives
Table 84. Wuxi AppTec Inc. Profiles
Table 85. Wuxi AppTec Inc. Clinical Trials Product Introduction
Table 86. Wuxi AppTec Inc. Clinical Trials Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. Wuxi AppTec Inc. Strategic initiatives
Table 88. PRA Health Sciences Profiles
Table 89. PRA Health Sciences Clinical Trials Product Introduction
Table 90. PRA Health Sciences Clinical Trials Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. PRA Health Sciences Strategic initiatives
Table 92. Chiltern International Ltd. Profiles
Table 93. Chiltern International Ltd. Clinical Trials Product Introduction
Table 94. Chiltern International Ltd. Clinical Trials Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. Chiltern International Ltd. Strategic initiatives
Table 97. INC Research Profiles
Table 98. INC Research Clinical Trials Product Introduction
Table 99. INC Research Clinical Trials Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. INC Research Strategic initiatives
